Sign in

CIK 0001472012

  • Non-accelerated filer

Immunome Inc.

Sign in to watch
Ticker
IMNM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
770694340
Phone
+1 610-321-3700
Business address
18702 N. CREEK PARKWAY, SUITE 100, BOTHELL, WA, 98011
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$334,224
in 1 filing, $334K under 10b5-1 plans

Net −$334,224. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Higgins Jack −$334K Chief Scientific Officer sold 17% of stake
Date Insider Transaction Shares Price Value Owned after
2023-06-08 Lefenfeld Michael Director Grant or award · Stock Option (Right to Buy) +6,500 6,500
2023-01-15 Lefenfeld Michael Director Grant or award +13,875 $4.00 $56K 40,747
2022-06-16 Lefenfeld Michael Director Grant or award · Stock Option (Right to Buy) +6,500 6,500
2021-05-28 Lefenfeld Michael Director Grant or award · Stock Option (Right to Buy) +3,750 3,750
2021-05-26 Lefenfeld Michael Director Purchase +1,335 $19.03 $25K 26,872
2021-05-25 Lefenfeld Michael Director Purchase +2,715 $18.44 $50K 25,537
2021-05-24 Lefenfeld Michael Director Purchase +600 $17.80 $11K 22,822
2020-11-03 Lefenfeld Michael Director Grant or award · Stock Option (Right to Buy) +7,500 7,500
2020-10-06 Lefenfeld Michael Director Conversion +22,222 22,222
2020-10-06 Lefenfeld Michael Director Conversion · Series A Convertible Preferred Stock −22,222 0
2020-10-06 Lefenfeld Michael Director Conversion · Warrant (right to buy) −11,111 0
2020-10-06 Lefenfeld Michael Director Conversion · Warrant (right to buy) +11,111 11,111

Page 1 of 1 · 12 trades